Further evidence on the high proficiency of laboratories involved in plasma pool testing for HCV RNA by nucleic acid amplification technology [1]

Vox Sanguinis

Volumn 82, Issue 4, 2002, Pages 211-212

  Pisani, G ^a   Cristiano, K ^a   Wirz, M ^a   Bisso, G ^a   Gentili, G ^a   Fang, R ^a   Hertig, C ^a   Mincione, T ^a   Santirocco, N ^a   Salvoni, G ^a   Piani, M ^a   Jochum, C ^a   Gajardo, R ^a   Vitali, M S ^a   Iudicone, P ^a   Miceli, M ^a   Streichert, S ^a   Broch, I ^a   Zucchini, A ^a   Gambelli, D ^a   Pichl, L ^a   Stolz, M ^a   Aberham, C ^a   Gessner, M ^a   Gartner T ^a   more..

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARGENTINA; CALIBRATION; CLINICAL ARTICLE; GERMANY; HUMAN; INTERNATIONAL COOPERATION; LABORATORY DIAGNOSIS; LETTER; MEDICAL LITERATURE; NUCLEIC ACID AMPLIFICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RNA ANALYSIS; SWITZERLAND; VALIDATION PROCESS;

BLOOD TRANSFUSION; EUROPE; GUIDELINE ADHERENCE; HEPACIVIRUS; HUMANS; LABORATORIES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PLASMA; QUALITY CONTROL; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 0036589037     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2002.00180.x     Document Type: Letter

References (5)

1. Gentili G, Pisani G, Bisso G, Cristiano K, Wirz M, Mele C and the EQA participants: Hepatitis C virus testing of plasma pools by nucleic acid amplification technology: External quality assessment. Vox Sang 2001; 81:143-147
2. Committee for Proprietary Medicinal Products: The Introduction of Nucleic Acid Amplification Technology (NAT) for the Detection of Hepatitis C Virus in Plasma Pools (CPMP/BWP/390/97). Addendum to note for guidance on plasma derived medicinal products (CPMP/BWP/269/95). London, CPMP, 1997
3. The European Department for the Quality of Medicines: Human plasma for fractionation (2000:0853). In: European Pharmacopoeia, 3rd Edn. (Supplement 2000). Strasbourg, France, Council of Europe, 2000, 801-802
4. Saldanha J, Lelie N, Heath A and the WHO collaborative study group: Establishment of the first International Standard for nucleic acid amplification technology (NAT) assays for HCV RNA. Vox Sang 1999; 76:149-158
5. Saldanha J, Heath A, Lelie N, Pisani G, Nubling M, Yu M and the collaborative study group: Calibration of HCV working reagents for NAT assays against the HCV International Standard. Vox Sang 2000; 78:217-222